Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Determinants of Willingness to Undergo Lung Cancer Screening among High-Risk Current and Ex-smokers in Sabah, Malaysia: A Cross-Sectional Pilot Study

  • Received : 2023.03.10
  • Accepted : 2023.08.28
  • Published : 2023.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Attitudes towards smoking, lung cancer screening, and perceived risk of lung cancer have not been widely studied in Malaysia. The primary objective of this study was to describe the factors affecting the willingness of high-risk current smokers and ex-smokers to undergo low-dose computed tomography (LDCT) screening for lung cancer. Methods: A prospective, cross-sectional questionnaire study was conducted in current smokers or ex-smokers aged between 55 and 80 years at three hospitals in Kota Kinabalu, Sabah, Malaysia. The questionnaire recorded the following parameters: perceived lung cancer risk; Prostate Lung Colon Ovarian Cancer 2012 risk prediction model excluding race and ethnicity predictor (PLCOm2012norace); demographic characteristics; psychosocial characteristics; and attitudes towards lung cancer and lung cancer screening. Results: A vast majority of the 95 respondents (94.7%) indicated their willingness to undergo screening. Stigma of lung cancer, low levels of knowledge about lung cancer symptoms, concerns about financial constraints, and a preference for traditional medication were still prevalent among the respondents, and they may represent potential barriers to lung cancer screening uptake. A desire to have an early diagnosis (odds ratio [OR], 11.33; 95% confidence interval [CI], 1.53 to 84.05; p=0.02), perceived time constraints (OR, 3.94; 95% CI, 1.32 to 11.73; p=0.01), and proximity of LDCT screening facilities (OR, 14.33; 95% CI, 1.84 to 111.4; p=0.01) had significantly higher odds of willingness to undergo screening. Conclusion: Although high-risk current smokers and ex-smokers are likely to undergo screening for lung cancer, several psychosocial barriers persist. The results of this study may guide the policymakers and clinicians regarding the need to improve lung cancer awareness in our population.

Keywords

Acknowledgement

The authors would like to thank Universiti Malaysia Sabah for sponsoring the publication fees of this article.

References

  1. Azizah AM, Nor Saleha IT, Noor Hashimah A, Asmah ZA, Mastulu W. Malaysian National Cancer Registry Report 2007-2011. Putrajaya: National Cancer Institute, Ministry of Health, Malaysia; 2016. 
  2. Field JK, Vulkan D, Davies MP, Baldwin DR, Brain KE, Devaraj A, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg Health Eur 2021;10:100179. 
  3. Rajadurai P, How SH, Liam CK, Sachithanandan A, Soon SY, Tho LM. Lung cancer in Malaysia. J Thorac Oncol 2020;15:317-23.  https://doi.org/10.1016/j.jtho.2019.10.021
  4. Loh JF, Tan SL. Lung cancer knowledge and screening in the context of the Malaysian population. J Pharm Pract Res 2018;48:56-64.  https://doi.org/10.1002/jppr.1341
  5. Kok WH, Ban Yu-Lin A, Azhar Shah S, Abdul Hamid F. Determining the perception of a lung cancer screening programme among high-risk patients in a tertiary referral centre, Kuala Lumpur. Proc Singap Healthc 2020;29:19-24.  https://doi.org/10.1177/2010105819891743
  6. Economic Planning Unit. Twelfth Malaysia Plan 2021-2025: a prosperous, inclusive, sustainable Malaysia [Internet]. Putrajaya: Ministry of Economy, Malaysia; 2022 [cited 2023 Sep 7]. Available from: https://rmke12.epu.gov.my/en. 
  7. Pasquinelli MM, Tammemagi MC, Kovitz KL, Durham ML, Deliu Z, Rygalski K, et al. Risk prediction model versus United States preventive services task force lung cancer screening eligibility criteria: reducing race disparities. J Thorac Oncol 2020;15:1738-47.  https://doi.org/10.1016/j.jtho.2020.08.006
  8. US Preventive Services Task Force; Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for lung cancer: US Preventive Services task force recommendation statement. JAMA 2021;325:962-70.  https://doi.org/10.1001/jama.2021.1117
  9. See K, Manser R, Park ER, Steinfort D, King B, Piccolo F, et al. The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey. ERJ Open Res 2020;6:00158-2019.  https://doi.org/10.1183/23120541.00158-2019
  10. Quaife SL, Brain KE, Stevens C, Kurtidu C, Janes SM, Waller J. Development and psychometric testing of the self-regulatory questionnaire for lung cancer screening (SRQ-LCS). Psychol Health 2022;37:194-210.  https://doi.org/10.1080/08870446.2021.1879806
  11. Tammemagi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al. Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014;11:e1001764. 
  12. Daniel WW. Biostatistics: a foundation for analysis in the health sciences. 7th ed. New York: John Wiley & Sons; 1999. 
  13. Institute for Public Health (IPH), National Institutes of Health, Ministry of Health Malaysia. National Health and Morbidity Survey (NHMS) 2019. Vol. I: NCDs: non-communicable diseases: risk factors and other health problems. Kuala Lumpur: Ministry of Health Malaysia; 2020. 
  14. Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, et al. Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester. Thorax 2019;74:405-9.  https://doi.org/10.1136/thoraxjnl-2017-211377
  15. Quaife SL, Vrinten C, Ruparel M, Janes SM, Beeken RJ, Waller J, et al. Smokers' interest in a lung cancer screening programme: a national survey in England. BMC Cancer 2018;18:497. 
  16. Hestbech MS, Siersma V, Dirksen A, Pedersen JH, Brodersen J. Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 2011;73:325-31.  https://doi.org/10.1016/j.lungcan.2010.12.018
  17. Huang J, Yue N, Wu J, Shi N, Wang Q, Cui T, et al. Screening rate and influential factors of lung cancer with low-dose computed tomography in Asian population: a systematic review and meta-analysis. J Public Health (Oxf) 2022;44:246-54.  https://doi.org/10.1093/pubmed/fdaa225
  18. Zhou F, Zhou C. Lung cancer in never smokers: the East Asian experience. Transl Lung Cancer Res 2018;7:450-63.  https://doi.org/10.21037/tlcr.2018.05.14
  19. Yang W, Qian F, Teng J, Wang H, Manegold C, Pilz LR, et al. Community-based lung cancer screening with low-dose CT in China: results of the baseline screening. Lung Cancer 2018;117:20-6. https://doi.org/10.1016/j.lungcan.2018.01.003